- Home
- PG vs JNJ Comparison
PG vs JNJ Comparison
Compare PG & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PG
- JNJ
- Stock Information
- Founded
- PG 1837
- JNJ 1886
- Country
- PG United States
- JNJ United States
- Employees
- PG N/A
- JNJ 139800
- Industry
- PG Package Goods/Cosmetics
- JNJ Biotechnology: Pharmaceutical Preparations
- Sector
- PG Consumer Discretionary
- JNJ Health Care
- Exchange
- PG Nasdaq
- JNJ Nasdaq
- Market Cap
- PG 350.3B
- JNJ 449.6B
- IPO Year
- PG N/A
- JNJ 1944
- Fundamental
- Price
- PG $150.10
- JNJ $187.45
- Analyst Decision
- PG Buy
- JNJ Buy
- Analyst Count
- PG 14
- JNJ 16
- Target Price
- PG $174.43
- JNJ $196.19
- AVG Volume (30 Days)
- PG 7.4M
- JNJ 8.3M
- Earning Date
- PG 10-24-2025
- JNJ 10-14-2025
- Dividend Yield
- PG 2.84%
- JNJ 2.79%
- EPS Growth
- PG 18.18
- JNJ 71.26
- EPS
- PG 6.85
- JNJ 10.35
- Revenue
- PG $84,933,000,000.00
- JNJ $92,149,000,000.00
- Revenue This Year
- PG $6.22
- JNJ $6.63
- Revenue Next Year
- PG $3.03
- JNJ $5.31
- P/E Ratio
- PG $21.72
- JNJ $18.03
- Revenue Growth
- PG 1.23
- JNJ 5.08
- 52 Week Low
- PG $146.97
- JNJ $140.68
- 52 Week High
- PG $180.43
- JNJ $194.48
- Technical
- Relative Strength Index (RSI)
- PG 44.58
- JNJ 50.02
- Support Level
- PG $148.47
- JNJ $184.66
- Resistance Level
- PG $153.17
- JNJ $194.00
- Average True Range (ATR)
- PG 2.28
- JNJ 2.69
- MACD
- PG 0.13
- JNJ -1.10
- Stochastic Oscillator
- PG 30.04
- JNJ 28.41
About PG Procter & Gamble Company (The)
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.